Tempest Therapeutics appoints Nicholas Maestas as VP, Strategy and Finance and PFO

Tempest Therapeutics, Inc.

Appointed Nicholas Maestas, age 41, as VP, Strategy and Finance and principal financial officer, effective July 12, 2021.
Maestas previously served as head of FP&A and strategic finance at Alector, Inc. since 2019.
Base salary of $325,000; eligible for annual performance bonus with target of 30% of base salary.
Granted option to purchase 23,225 common shares at July 12 closing price; vests 25% at 1 year, then monthly over 48 months.
Severance: 3 months salary/benefits outside change of control; 6 months salary plus 50% bonus and accelerated vesting during change of control.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nicholas Maestas

vice president, strategy and finance and principal financial officer

TPST · Tempest Therapeutics, Inc.

Effective: 2021-07-12
Filed: July 12, 2021, 7:59 PM ET

On July 12, 2021, Nicholas Maestas, age 41, joined Tempest Therapeutics, Inc. (the “Company”) as vice president, strategy and finance and is the Company’s principal financial officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicholas Maestas was appointed as vice president, strategy and finance and principal financial officer at Tempest Therapeutics, Inc..

Action: appointed
Role: vice president, strategy and finance and principal financial officer

Exact text from the filing

On July 12, 2021, Nicholas Maestas, age 41, joined Tempest Therapeutics, Inc. (the “Company”) as vice president, strategy and finance and is the Company’s principal financial officer.

View on SEC.gov

Tempest Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-212534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.